Morin augments anticarcinogenic and antiproliferative efficacy against 7,12-dimethylbenz(a)-anthracene induced experimental mammary carcinogenesis

Molecular and Cellular Biochemistry

Volumn 364, Issue 1-2, 2012, Pages 79-92

  Nandhakumar, Ramadass ^a   Salini, Kombiyil ^a   Devaraj, Sivasithambaram Niranjali ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

DMBA; Mammary carcinoma; Morin; Oxidative stress; PCNA

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ALPHA FETOPROTEIN; ALPHA TOCOPHEROL; ASCORBIC ACID; CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CATALASE; CYCLINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROPEROXIDE; MORIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BODY WEIGHT; BREAST CARCINOGENESIS; BREAST CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; NONHUMAN; RAT; TUMOR VOLUME; ULTRASTRUCTURE;

ANIMALS; ANTIOXIDANTS; BENZ(A)ANTHRACENES; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY NEOPLASMS, ANIMAL; NEOPLASMS, EXPERIMENTAL; OXIDATIVE STRESS; RATS;

ANIMALIA; RATTUS;

EID: 84863987549     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-1207-5     Document Type: Article

References (62)

1. Smymiotis V, Theodosopoulos T, Marinis A, Goula K, Psychogios J, Kondi-Pafiti A (2005) Metastatic disease in the breast from nonmammary neoplasms. Eur J Gynaecol Oncol 26:547-550 (Pubitemid 41585943)
2. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153-156 (Pubitemid 32911406)
3. Bryle P, Leon ME, Maisonneuve P, Autier P (2003) Cancer control in women. Update 2003. Int J Gynaecol Obstet 83:179-202 (Pubitemid 39658501)
4. ICMR. National Cancer Registry Programme, 1981-2001, An Overview. Indian Council of Medical Research, New Delhi. April 2002
5. Russo IH, Russo J (1978) Developmental stage of the rat mammary gland as determinant of its susceptibility to 7, 12-dimethylbenz (a) anthracene. J Natl Cancer Inst 61:1439-1449 (Pubitemid 9070679)
6. Russo J, Lee KT, Ciocca DR, Russo IH (1983) Molecular and cellular basis of the mammary gland susceptibility to carcinogenesis. Environ Health Perspect 49:185-199 (Pubitemid 13098355)
7. Rakesh S, Kline RP, Wu EX, Katz JK (2005) Rapid in vivo Taxotere quantitative chemosensitivity response by 4.23 Tesla sodium MRI and histo-immunostaining features in N-Methyl-NNitrosourea induced breast tumors in rats. Cancer Cell Int 5:26-45
8. Aggarwal BB, Shishodia S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71:1397-1421
9. Subhashinee SK, Wijeratne M, Abou-Zaid M, Shahidi F (2006) Antioxidant polyphenols in almond and its coproducts. J Agric Food Chem 54:312-318
10. Romero I, Páez A, Ferruelo A, Luján M, Berenguer A (2002) Polyphenols in red wine inhibit the proliferation and induce apoptosis of LNCaP cells. BJU Int 89:950-954 (Pubitemid 34535434)
11. Wu TW, Zeng LH, Wu J, Fung KP (1993) Morin hydrate is a plant derived antioxidant-based hepatoprotector. Life Sci 53:213-218
12. Fang SH, Hou YC, Chang WC, Hsiu SL, Chao PD, Chiang BL et al (2003) Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life Sci 74:743-756
13. Kawabata K, Tanaka T, Honjo S, Kakumoto M, Hara A, Makita H, Tatematsu N, Ushida J, Tsuda H, Mori H (1999) Chemopreventive effect of dietary flavonoid morin on chemically induced rat tongue carcinogenesis. Int J Cancer 83:381-386 (Pubitemid 29455762)
14. Kuo HM, Chang LS, Lin YL, Lu HF, Yang JS, Lee JH, Chung (2007) Morin inhibits the growth of human leukemia HL-60 cells via cell cycle arrest and induction of apoptosis through mitochondria dependent pathway. Anticancer Res 27:395-406 (Pubitemid 46363359)
15. Iwase Y, Takemura Y, Juichi M, Muainaka T, Ichiishi E, Ito C (2001) Inhibitory effect of flavonoid derivatives on Epstein-Barr virus activation and two stage carcinogensis of skin tumours. Cancer Lett 173:105-109 (Pubitemid 32971926)
16. Wu TW, Zeng LH, Wu J, Fung KP (1994) Morin: a wood pigment that protects three types of human cells in the cardiovascular system against oxyradical damage. Biochem Pharmacol 47:1099-1103 (Pubitemid 24103845)
17. Kok LD, Wong YP, Wu TW, Chan HC, Kwok TT, Fung KP (2000) Morin hydrate: a potential antioxidant in minimizing the free-radicals-mediated damage to cardiovascular cells by antitumor drugs. Life Sci 67:91-99 (Pubitemid 30368626)
18. Zhanga R, Kanga KA, Piaoa MJ, Maenga YH, Leea KH, Changa WY, Youb HJ, Kimc JS, Kangc SS, Hyun JW (2009) Cellular protection of morin against the oxidative stress induced by hydrogen peroxide. Chem Biol Interact 177:21-27
19. Ishige K, Schubert D, Sagara Y (2001) Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med 30:433-446 (Pubitemid 32155542)
20. Ibarretxe G, Sánchez-Gómez MV, Campos-Esparza MR, Alberdi E, Matute C (2006) Differential oxidative stress in oligodendrocytes and neurons after excitotoxic insults and protection by natural polyphenols. Glia 53:201-211
21. Damianaki A, Bakogeorgou E, Kampa M, Notas G, Hatzoglou A, Panagiotou S, Gemetzi C, Kouroumalis E, Martin PM, Castanas E (2000) Potent inhibitory action of red wine polyphenols on human breast cancer cells. J Cell Biochem 78:429-441 (Pubitemid 30491071)
22. Nesaretnam K, Hales E, Sohail M, Krausz T, Darbre P (1998) 3, 30, 4, 40-Tetrachlorobiphenyl (TCB) can enhance DMBA-induced mammary carcinogenesis in the rat. Eur J Cancer 34:389-393 (Pubitemid 28183840)
23. Harris RE, Alshafie GA, Abou-Issa H, Seibert K (2000) Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res 60:2101-2103 (Pubitemid 30225166)
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
25. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358 (Pubitemid 9194347)
26. Jiang ZY, Hunt JY, Wolff SP (1992) Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 202:384-389
27. Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469-474
28. Sinha AK (1972) Colorimetric assay of catalase. Anal Biochem 47:389-394
29. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG (1973) Selenium: biochemical role as a component of glutathione peroxidase. Science 179:588-590
30. Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67-78 (Pubitemid 9065588)
31. Staal G E J, Visser J, Veeger C (1969) Purification and properties of glutathione reductase of human erythrocytes. Biochim Biophys Acta 185:39-48
32. Omaye ST, Turnbull JD, Sauberlich HE (1979) Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods Enzymol 62:3-11
33. Desai ID (1984) Vitamin E analysis methods for animal tissues. Methods Enzymol 105:138-147 (Pubitemid 14165381)
34. Aubele M, Bieterferd S, Derenzini M, Hufnagl P, Martin H, Öfner D, Ploton D, Rüschoff J (1994) Guidelines of AgNOR quantitation. Zentralbl Pathol 140:107-108
35. Macnab GM, Urbanowicz JM, Kew MC (1978) Carcinoembryonic antigen in hepatocellular cancer. Br J Cancer 38:51-54
36. Abdi S, Ali A (1999) Role of oxygen free radicals in the pathogenesis and etiology of cancer. Cancer Lett 142:1-9 (Pubitemid 29281560)
37. Janssen AM, Bosman CB, Van Duijn W, Oostendorp-van de Ruit MM, Kubben FJ, Griffioen G, Lamers CB, Van Krieken JH, van de Velde CJ, Verspaget HW (2000) Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. Clin Cancer Res 6:3183-3192 (Pubitemid 30637746)
38. Talas ZS, Ozdemir I, Yilmaz I, Gok Y (2009) Antioxidative effects of novel synthetic organoselenium compound in rat lung and kidney. Ecotoxicol Environ Saf 72:916-921
39. McCord JM, Fridovich I (1969) The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen. J Biol Chem 244:6056-6063
40. Thirunavukkarasu C, Sakthisekaran D (2001) Effect of selenium on N-nitrosodiethylamine-induced multistage hepatocarcinogenesis with reference to lipid peroxidation and enzymic antioxidants. Cell Biochem Funct 19:27-35 (Pubitemid 32178742)
41. Meister, Anderson ME (1983) Glutathione. Annu Rev Biochem 52:711-760 (Pubitemid 13030692)
42. Anoopkumar-Dukie S, Walker RB, Daya S (2001) A sensitive and reliable method for the detection of lipid peroxidation in biological tissues. J Pharm Pharmacol 53:263-266 (Pubitemid 32156522)
43. Rao AV, Shaha C (2000) Role of glutathione S-transferases in oxidative stress-induced male germ cell apoptosis. Free Radic Biol Med 29:1015-1027
44. Masella R, Benedetto RD, Varý R, Filesi C, Giovannini C (2005) Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. J Nutr Biochem 16:577-586 (Pubitemid 41338369)
45. Swenberg JA, Hoel DG, Magee PN (1991) Mechanistic and statistical insight into the large carcinogenesis bioassays on jYnitrosodiethylamine and jY-nitrosodimethylamine. Cancer Res 51:6409-6414
46. Ketterer B, Meyer DJ (1989) Glutathione transferases: a possible role in the detoxication and repair of DNA and lipid hydroperoxides. Mutat Res 214:33-40 (Pubitemid 19220284)
47. van Poppel G, van den Berg H (1997) Vitamins and cancer. Cancer Lett 114:195-202 (Pubitemid 27140112)
48. Stocker R, Bowry VW, Frei B (1991) Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci USA 88:1646-1650 (Pubitemid 21916282)
49. Gall JG, Pardue ML (1969) Formation and detection of RNA-DNA hybrid molecules in cytological preparations. Proc Natl Acad Sci USA 63:378-383
50. Derenzini M, Ploton D (1991) Interphase nucleolar organizer regions in cancer cells. Int Rev Exp Pathol 32:150-192
51. Derenzini M, Pession A, Trerè D (1990) Quantity of nucleolar silver-stained proteins is related to proliferative activity in cancer cells. Lab Invest 63:137-140 (Pubitemid 20234683)
52. Sirri V, Roussel P, Trerè D, Derenzini M, Hernandez-Verdun D (1995) Amount variability of total and individual Ag-NOR proteins in cells stimulated to proliferate. J Histochem Cytochem 43:887-893
53. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H (1987) Cyclin/PCNA is the auxiliary protein of DNA polymerase-d. Nature 326:515-517 (Pubitemid 17055498)
54. Leonardi E, Girlando S, Serio G, Mauri FA, Perrone G, Scampini S, Dalla Palma P, Barbareschi M (1992) PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables. J Clin Pathol 45:416-419
55. Cheung KL, Graves C R L, Robertson J F R (2000) Tumor marker measurements in the diagnosis and monitoring of breast cancer. Cancer Treat Rev 26:91-102 (Pubitemid 30182241)
56. Sikorska H, Shuster J, Gold P (1988) Clinical applications of carcinoembryonic antigen. Cancer Detect Prevent 12:321-355
57. Go V L W, Zamcheck N (1982) The role of tumor markers in the management of colorectal cancer. Cancer 50:2618-2623 (Pubitemid 13220849)
58. Haagensen DE, Kister SJ, Vandevoorde JP, Gates JB, Smart EK, Hansen HJ, Wells SA (1978) Evaluation of carcinoembryonic antigen as a plasma monitor for human breast carcinoma. Cancer 42:1512-1519 (Pubitemid 9038285)
59. Sell S, Becker F, Leffert HL, Osborn K, Salman J, Lombardi B, Shinozuka H, Reddy J, Roushlahti E, Sala-Trepat J (1983) a-Fetoprotein as a marker for early events and carcinoma development during chemical hepatocarcinogenesis. Environ Sci Res 29:271-293
60. Duffy MJ (2001) Biochemical markers in breast cancer: which ones are clinically useful? Clin Biochem 34:347-352 (Pubitemid 32777841)
61. Kallioniemi OP, Oksa H, Aaran RK et al (1988) Serum CA 15-3 assay in the diagnosis and follow-up of breast cancer. Br J Cancer 58:213-215
62. Bast RC Jr, Ravdin P, Hayes DF, Bates S, Fritsche H Jr, Jessup JM, Kemeny N, Locker GY, Mennel RG, Somerfield MR (2001) American Society of Clinical Oncology Tumor Markers Expert Panel 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1865-1878 (Pubitemid 32230890)